Publicaciones en colaboración con investigadores/as de VU University Medical Center (6)

2020

  1. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling

    Biological Psychiatry, Vol. 87, Núm. 2, pp. 100-112

2013

  1. Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: The European Forsteo Observational Study

    BMC Musculoskeletal Disorders, Vol. 14

2012

  1. Effectiveness of teriparatide in postmenopausal women with osteoporosis and glucocorticoid use: 3-Year results from the EFOS study

    Journal of Rheumatology, Vol. 39, Núm. 3, pp. 600-609

  2. Effectiveness of teriparatide in women over 75 years of age with severe osteoporosis: 36-month results from the European Forsteo Observational Study (EFOS)

    Calcified Tissue International, Vol. 90, Núm. 5, pp. 373-383

  3. Effects of teriparatide in postmenopausal women with osteoporosis pre-treated with bisphosphonates: 36-month results from the European Forsteo Observational Study

    European Journal of Endocrinology, Vol. 166, Núm. 1, pp. 87-97

1997

  1. Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

    Journal of Neuroimmunology, Vol. 80, Núm. 1-2, pp. 172-178